Spruce Biosciences, Inc. (SPRB)
39.65
-1.82
(-4.39%)
USD |
NASDAQ |
Oct 16, 16:00
40.00
+0.35
(+0.88%)
After-Hours: 20:00
Spruce Biosciences EPS Diluted (Quarterly) : -6.676 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -6.676 |
| March 31, 2026 | -8.940 |
| December 31, 2025 | -10.67 |
| September 30, 2025 | -14.58 |
| June 30, 2025 | -3.496 |
| March 31, 2025 | -0.3195 |
| December 31, 2024 | -42.72 |
| September 30, 2024 | -0.2099 |
| June 30, 2024 | -0.223 |
| March 31, 2024 | -0.2829 |
| December 31, 2023 | -0.2425 |
| September 30, 2023 | -0.3035 |
| June 30, 2023 | -0.3163 |
| March 31, 2023 | -0.401 |
| Date | Value |
|---|---|
| December 31, 2022 | -0.4729 |
| September 30, 2022 | -0.4839 |
| June 30, 2022 | -0.5053 |
| March 31, 2022 | -0.5007 |
| December 31, 2021 | -0.3916 |
| September 30, 2021 | -0.4899 |
| June 30, 2021 | -0.5047 |
| March 31, 2021 | -0.4246 |
| December 31, 2020 | -0.3585 |
| September 30, 2020 | -0.413 |
| June 30, 2020 | -20.83 |
| March 31, 2020 | -0.2222 |
| December 31, 2019 | -10.28 |
| September 30, 2019 | -0.1099 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -16.23M |
| Total Expenses (Quarterly) | 16.23M |
| Enterprise Value | 20.53M |
| Earnings Yield | -103.1% |
| Normalized Earnings Yield | -97.93 |